Vascular disease and ischemic stroke in patients with atrial fibrillation: Temporal trends and age-related differences

被引:0
作者
Teppo, Konsta [1 ,2 ,6 ]
Karlsson, Elin [3 ]
Kiviniemi, Tuomas [1 ,2 ]
Halminen, Olli [4 ]
Lehtonen, Ossi [5 ]
Kouki, Elis [3 ]
Haukka, Jari [3 ]
Mustonen, Pirjo [2 ,6 ]
Putaala, Jukka [3 ,7 ]
Linna, Miika [4 ,5 ]
Hartikainen, Juha [5 ,8 ]
Airaksinen, K. E. Juhani [1 ,2 ]
Lehto, Mika [3 ,9 ]
机构
[1] Turku Univ Hosp, Heart Ctr, Turku, Finland
[2] Univ Turku, Turku, Finland
[3] Univ Helsinki, Helsinki, Finland
[4] Aalto Univ, Espoo, Finland
[5] Univ Eastern Finland, Kuopio, Finland
[6] Turku Univ Hosp, Turku 20500, Finland
[7] Helsinki Univ Hosp, Dept Neurol, Helsinki, Finland
[8] Kuopio Univ Hosp, Kuopio, Finland
[9] HUS Helsinki Univ Hosp, Jorvi Hosp, Dept Internal Med, Helsinki, Finland
关键词
Atrial fibrillation; Vascular disease; Coronary artery disease; Peripheral artery disease; Ischemic stroke; Temporal trends; RISK-FACTORS; ATHEROSCLEROSIS; METAANALYSIS; PREVALENCE; ADULTS;
D O I
10.1016/j.atherosclerosis.2024.118590
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: We examined temporal trends and age-related differences in the prevalence of vascular diseases and in their association with ischemic stroke (IS) risk in patients with atrial fibrillation (AF). Methods: The registry-based FinACAF study covered all patients with AF in Finland during 2007-2018. Incidence rate ratios (IRRs) of IS were computed with Poisson regression, and the interaction of vascular diseases with age and calendar year period was assessed. Results: We identified 229,565 patients (50.0 % female; mean age 72.7 years) with incident AF. The overall prevalence of any vascular disease was 28.6 %, and the prevalence increased from 2007 to 2018, primarily among patients over 75 years. Overall, 5909 (2.6 %) patients experienced IS within the first year after AF diagnosis. Crude IS rate decreased continuously during the study period in both patients with and without vascular diseases, with the rates remaining consistently higher in patients with vascular diseases. Vascular diseases were independently associated with higher IS incidence among patients under 65 years (adjusted IRR with 95 % confidence interval 1.35 (1.10-1.66)), while among older patients, only peripheral artery disease was associated with IS, and other vascular conditions had no association with IS. No interactions between the calendar year period and vascular diseases with IS rate were observed. Conclusions: The association between vascular diseases and IS has remained stable over time and vascular diseases were independently associated with higher incidence of IS particularly in patients with AF under the age of 65.
引用
收藏
页数:8
相关论文
共 45 条
  • [1] Lehto M., Haukka J., Aro A., Halminen O., Putaala J., Linna M., Et al., Comprehensive nationwide incidence and prevalence trends of atrial fibrillation in Finland, Open Heart, 9, (2022)
  • [2] Lip G.Y.H., Nieuwlaat R., Pisters R., Lane D.A., Crijns H.J.G.M., Andresen D., Et al., Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation, Chest, 137, (2010)
  • [3] Bjorck S., Palaszewski B., Friberg L., Bergfeldt L., Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study, Stroke, 44, (2013)
  • [4] Libby P., Buring J.E., Badimon L., Hansson G.K., Deanfield J., Bittencourt M.S., Et al., Atherosclerosis (primer), Nat. Rev. Dis. Prim., 5, (2019)
  • [5] Song P., Rudan D., Zhu Y., Fowkes F.J.I., Rahimi K., Fowkes F.G.R., Et al., Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis, Lancet Global Health, 7, (2019)
  • [6] Mone P., Morgante M., Pansini A., Jankauskas S.S., Rizzo M., Lombardi A., Et al., Effects of insulin resistance on mitochondrial (dys)function, Atherosclerosis, 341, (2022)
  • [7] Gambardella J., Wang X., Mone P., Khondkar W., Santulli G., Genetics of adrenergic signaling drives coronary artery calcification, Atherosclerosis, 310, (2020)
  • [8] Frostegard J., Immunity, atherosclerosis and cardiovascular disease, BMC Med., 11, (2013)
  • [9] Raggi P., Genest J., Giles J.T., Rayner K.J., Dwivedi G., Beanlands R.S., Et al., Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions, Atherosclerosis, 276, (2018)
  • [10] Song P., Fang Z., Wang H., Cai Y., Rahimi K., Zhu Y., Et al., Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study, Lancet Global Health, 8, (2020)